Literature DB >> 31460800

Sanitation and diarrhoea in infancy and CRP level at 18 years: the birth-to-twenty plus cohort.

Rihlat Said-Mohamed1, Aryeh D Stein1,2, John M Pettifor1, Shane A Norris1,2.   

Abstract

Background: Cardiometabolic disease is associated with chronic low-grade inflammation. While low birthweight, childhood stunting and rapid weight gain predict higher adult high-sensitivity C-reactive protein (hs-CRP) concentrations, associations between childhood infections and adulthood CRP are inconsistent.Aim: To assess the associations between sanitation, diarrhoea and a combined score of both from birth to age 2 years and hs-CRP at age 18 years, independently of early life nutrition and adult adiposity.Subjects and methods: This study collected data on sanitation and diarrhoea episodes from birth to 2 years on 756 participants of the Birth-to-Twenty Plus cohort, a birth cohort initiated in South Africa in 1990, and calculated a combined score of both variables. Anthropometry was measured at 2 years and 18 years and hs-CRP at 18 years.
Results: Of the participants, 29.5% had no access to indoor flush sanitation and 38.2% experienced ≥1 diarrhoea episode between birth and 2 years. Not having access to indoor flush sanitation and experiencing ≥1 diarrhoea episodes were associated with 1.50 mg/L and 1.52 mg/L higher hs-CRP, respectively. Prevalence of both burdens in infancy was associated with a 2.18 mg/L higher hs-CRP.
Conclusion: In this population, poor sanitation and diarrhoea in early life predict elevated CRP in young adulthood, independently of early life nutrition and adiposity.

Entities:  

Keywords:  Africa; Infection; adiposity; growth; low-grade inflammation

Year:  2019        PMID: 31460800     DOI: 10.1080/03014460.2019.1657496

Source DB:  PubMed          Journal:  Ann Hum Biol        ISSN: 0301-4460            Impact factor:   1.533


  1 in total

1.  Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021.

Authors:  Karoun H Bagamian; Chloe Puett; John D Anderson; Farzana Muhib; Clint Pecenka; Jere Behrman; Robert F Breiman; Ijeoma Edoka; Susan Horton; Gagandeep Kang; Karen L Kotloff; Claudio F Lanata; James A Platts-Mills; Firdausi Qadri; Elizabeth T Rogawski McQuade; Christopher Sudfeld; Pascale Vonaesch; Thomas F Wierzba; Suzanne Scheele
Journal:  Vaccine X       Date:  2022-09-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.